{"url_path":"/sec/piiiw/8-k/2026-06-10/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/1832511/0001832511-26-000027-index.html","accession_number":"0001832511-26-000027","cik":"0001832511","ticker":"PIII","issuer_name":"P3 Health Partners Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1832511/0001832511-26-000027-index.html","primary_entity_key":"0001832511","primary_entity_name":"P3 Health Partners Inc."},"word_count":287,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 9, 2026, P3 Health Partners Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Holders of the Company’s Class A common stock and Class V common stock as of the close of business on April 10, 2026, the record date for the Annual Meeting, were each entitled to one vote per share. The following are the voting results for the four proposals considered and voted upon at the Annual Meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 30, 2026.\n\nProposal 1 — Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2029, and until their respective successors have been duly elected and qualified.\n\nNOMINEEVotes FORVotes WITHHELDBroker Non-Votes\n\nAmir Bacchus, M.D.4,067,10032,162425,510\n\nMark Thierer4,081,57317,689425,510\n\nLawrence B. Leisure3,980,136119,126425,510\n\nProposal 2 — Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.\n\nVotes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes\n\n4,484,96339,585224—\n\nProposal 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers.\n\nVotes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes\n\n4,084,5839,7864,893425,510\n\nProposal 4 — Approval, in accordance with Nasdaq Listing Rule 5635(d), the issuance of up to 3,341,130 shares of Class A common stock upon the exercise of outstanding Class A common stock warrants held by VBC Growth SPV 5, LLC.\n\nVotes FORVotes AGAINSTVotes ABSTAINEDBroker Non-Votes\n\n4,064,69034,51557425,510\n\nBased on the foregoing votes, each of the three Class II director nominees were elected and Proposals 2, 3, and 4 were approved."}